Characterizing DNA methylation patterns driving chemotherapy resistance in ovarian high-grade serous carcinoma

被引：0
|
作者：
Lahtinen, Alexandra
Marchi, Giovanni
Lavikka, Kari
Micoli, Giulia
Holmstrom, Susanna
Pollanen, Elsi
Maarala, Ilari
Afenteva, Daria
Li, Yilin
Muranen, Taru A.
Oikkonen, Jaana
Huhtinen, Kaisa
Virtanen, Anni
Hynninen, Johanna
Hakkinen, Antti
Hautaniemi, Sampsa
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 05期
关键词：
D O I：
10.1158/1538-7445.OVARIAN23-A003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A003
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Characterizing dynamic landscape of DNA methylation in ovarian high-grade serous carcinoma
    Lahtinen, Alexandra
    Marchi, Giovanni
    Afenteva, Daria
    Holmstrom, Susanna
    Huhtinen, Kaisa
    Virtanen, Anni
    Hynninen, Johanna
    Hakkinen, Antti
    Hautaniemi, Sampsa
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Architectural Patterns of Ovarian/Pelvic High-grade Serous Carcinoma
    Bromley, Amy B.
    Altman, Alon D.
    Chu, Pamela
    Nation, Jill G.
    Nelson, Gregg S.
    Ghatage, Praful
    Kalloger, Steve E.
    Han, Guangming
    Koebel, Martin
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2012, 31 (05) : 397 - 404
  • [3] Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
    Arend, Rebecca C.
    Londono, Angelina I.
    Montgomery, Allison M.
    Smith, Haller J.
    Dobbin, Zachary C.
    Katre, Ashwini A.
    Martinez, Alba
    Yang, Eddy S.
    Alvarez, Ronald D.
    Huh, Warner K.
    Bevis, Kerri S.
    Straughn, J. Michael, Jr.
    Estes, Jacob M.
    Novak, Lea
    Crossman, David K.
    Cooper, Sara J.
    Landen, Charles N.
    Leath, Charles A., III
    MOLECULAR CANCER RESEARCH, 2018, 16 (05) : 813 - 824
  • [4] Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma
    Montgomery, A. M.
    Crossman, D. K.
    Yang, E. S.
    Alvarez, R. D.
    Huh, W. K.
    Bevis, K. S.
    Straughn, J. M., Jr.
    Leath, C. A., III
    Arend, R. C.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 12 - 13
  • [5] Acquired chemotherapy resistance in high-grade serous ovarian cancer patients.
    Christie, Elizabeth L.
    Beach, Jessica
    Etemadmoghadam, Dariush
    Garsed, Dale
    Patch, Ann-Marie
    Fereday, Sian
    Pattnaik, Swetansu
    Brady, Samuel
    Bild, Andrea
    Bowtell, David D. L.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 20 - 20
  • [6] Aberrant methylation of PCDH17 gene in high-grade serous ovarian carcinoma
    Baranova, Ivana
    Kovarikova, Helena
    Laco, Jan
    Dvorak, Ondrej
    Sedlakova, Iva
    Palicka, Vladimir
    Chmelarova, Marcela
    CANCER BIOMARKERS, 2018, 23 (01) : 125 - 133
  • [7] Personalising Treatment for High-Grade Serous Ovarian Carcinoma
    Cojocaru, E.
    Parkinson, C. A.
    Brenton, J. D.
    CLINICAL ONCOLOGY, 2018, 30 (08) : 515 - 524
  • [8] Molecular Management of High-Grade Serous Ovarian Carcinoma
    Punzon-Jimenez, Paula
    Lago, Victor
    Domingo, Santiago
    Simon, Carlos
    Mas, Aymara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [9] Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma
    Zibi Marchocki
    Alicia Tone
    Carl Virtanen
    Richard de Borja
    Blaise Clarke
    Theodore Brown
    Taymaa May
    Journal of Ovarian Research, 15
  • [10] Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma
    Marchocki, Zibi
    Tone, Alicia
    Virtanen, Carl
    de Borja, Richard
    Clarke, Blaise
    Brown, Theodore
    May, Taymaa
    JOURNAL OF OVARIAN RESEARCH, 2022, 15 (01)
12345